Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  SHENZHEN STOCK EXCHANGE  >  BGI Genomics Co., Ltd.    300676   CNE100003449

BGI GENOMICS CO., LTD.

(300676)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shenzhen Stock Exchange
10/20/2020 10/21/2020 10/22/2020 10/23/2020 10/26/2020 Date
144.83 141.9 137.96 132.83 134.57 Last
3222111 4151027 4519670 4483368 3304436 Volume
+0.23% -2.02% -2.78% -3.72% +1.31% Change
Financials
Sales 2020 7 276 M 1 088 M 1 088 M
Net income 2020 2 327 M 348 M 348 M
Net Debt 2020 - - -
P/E ratio 2020 22,8x
Yield 2020 0,12%
Sales 2021 5 134 M 768 M 768 M
Net income 2021 1 129 M 169 M 169 M
Net Debt 2021 - - -
P/E ratio 2021 47,1x
Yield 2021 0,05%
Capitalization 52 614 M 7 868 M 7 871 M
Capi. / Sales 2020 7,23x
Capi. / Sales 2021 10,2x
Nbr of Employees -
Free-Float 99,0%
More Financials
Company
BGI Genomics Co., Ltd. is a China-based company principally engaged in the diagnosis and research of genomics. The Company's main products and services include reproductive health basic research and clinical application services, basic science research services (genome sequencing, bioinformatics analysis and other multithreaded solutions), complex disease basic research and clinical application services, as well as... 
More about the company
Notations Surperformance© of BGI Genomics Co., Ltd.
Trading Rating : Investor Rating : -
More Ratings
All news about BGI GENOMICS CO., LTD.
09/23China's BGI wins 1.5 million coronavirus test kit order from Ethiopia
RE
09/23China's BGI wins 1.5 mln coronavirus test kit order from Ethiopia
RE
08/27BGI GENOMICS : WHO says it is in talks with China's BGI on test kit after Swedis..
RE
08/26BGI GENOMICS : China's BGI defends COVID-19 test kit after Swedish criticism
RE
08/24BGI GENOMICS CO., LTD. : half-yearly earnings release
08/05SPECIAL REPORT : COVID opens new doors for China's gene giant
RE
07/22BGI GENOMICS : Chinese genetics company BGI denies U.S. human rights accusations
RE
07/21U.S. adds 11 firms to economic blacklist over China's treatment of Uighurs
RE
07/20U.S. adds 11 firms to economic blacklist over China's treatment of Uighurs
RE
07/14BGI GENOMICS : China's BGI forecasts 700% jump in first-half profit due to COVID..
RE
05/14China's BGI gets Australian foothold through mass coronavirus test delivery
RE
05/06China's BGI gets Australian foothold through mass coronavirus test delivery
RE
01/23Chinese listed companies ramp up virus efforts after president's call
RE
More news
News in other languages on BGI GENOMICS CO., LTD.
08/26CORONAVIRUS : le point sur la pandémie
08/24BGI GENOMICS CO., LTD. : Veröffentlichung des Halbjahresergebnisses
08/24BGI GENOMICS CO., LTD. : publication des résultats semestriels
More news
Chart BGI GENOMICS CO., LTD.
Duration : Period :
BGI Genomics Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BGI GENOMICS CO., LTD.
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 3
Average target price
Last Close Price 132,83 
Spread / Highest target -
Spread / Average Target -
Spread / Lowest Target -
EPS Revisions
Managers
NameTitle
Ye Yin General Manager & Director
Jian Wang Chairman
Song Gang Li Chairman-Supervisory Board
Yi Qing Chen Chief Financial Officer
Jun Wang Director
Sector and Competitors
1st jan.Capitalization (M$)
BGI GENOMICS CO., LTD.93.35%7 868
EXACT SCIENCES CORPORATION18.62%16 473
GUARDANT HEALTH, INC.34.00%10 431
ADAPTIVE BIOTECHNOLOGIES CORPORATION65.44%6 722
SEEGENE INC--.--%6 083
INVITAE CORPORATION180.60%5 965